INTRODUCTION
Sooty mangabeys are among several species of African nonhuman primates which are naturally infected with the simian immunodeficiency virus (SIV) yel remain clinically asymptomatic (1] , When SIV is isolated from mangabeys and experimenlally injected into rhesus and pigtailed macaques. Ihese species develop an AIDS-like disease with the clinical symptoms of human MIV-1 infeclion [2] . The mechanism(s) by which the naturally infected African species remain clinically asymptomalic are currently unknown. Our laboralory has been studying the unmune response of naturally infected sooty mangabeys in an L-ITori to gain insight into the mechanisms of protective immunity in this species. Previously, we have shown that compared with the disease-suseeptible macaques, mangabeys have a high frequency and absolute number of circulating CD8 • T celis [3] . Furthermore, a great proportion of these cells appear to be activated, as they express HLA-DR on their cell surface. Finally, we have shown that CD8 ' • T eells in the mangabeys, but not the macaques, appear to play an important role in the immunosurvcillance system of this species |4], CDS' Tcells from HIV-I-infected humans and SI V-infected macaques have the ability to markedly inhibit HIV-1 and SIV replication, respectively, in vitro [5, 6] . The precise pathway by Correspondence: Dr A, A. Ansari. Winship Cancer Ccnlre, 1327 Clifton Road. NE, Room 5008, Atlanta. GA 30322. USA, which CD8+ cells mediate this inhibition remains to he elucidated. Furthermore, the protective role this inhibition may play in vivo is unclear.
Since sooty mangabeys are naturally infected with SIV without any clinical sequela, we endeavored to investigate these questions, using the mangabey model of SIV infection. Toward this goal, we have developed a ceil line derived from an SIVinfected mangabey which is replication-competent nol only for SiV but also to a lower but reproducible level for HIV-1 and HIV-2. In this study we demonstrate the ability of autologous CD8+ T cells to inhibit the replication of all three of these retroviruses in this cell line. In addition, by co-culturing SIVinfected cells with auiologous lymphocytes, using a dualchamber tissue culture vessel separated by a scmipermeable membrane, we provide evidence that there is no obligate requirement for cell-cell contact to mediate suppression of viral replication and that such suppression can be medialett by a soluble factor. Furthermore, experiments performed using an LTR-driven CAT reporter gene indicate thai CDK-T cells inhibit cellular activation of retroviral replication.
MATERIALS AND METHODS

Animals
All monkeys utilized in this study are housed at the Yerkes Regional Primate Research Centre (Atlanta. GA). They were maintained in accordance wilh the instructions of the Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources. National Research Council, and the PHS guidelines. Guide for the Care and Use of Laboratory Animals.
yiru.ses
The SIV used during this study was originally isolated from the peripheral blood mononuclear cells (PBMC) of a naturally infeeted sooty mangabey [I] by in vitro cocullurc with phytohaemagglutinin (PHA)-stiniulated human PBMC (courtesy of Dr P, Fultz. YRPRC. Emory University, Atlanta, GA). A large pool of this SI Vsmm-7 was prepared on contract withAdvanced Biotechnologies. Inc, (Silver Spring. MD), The virus was grown in ihc CD4' human cell line termed H-9 (courtesy ofthe NIH, AIDS Research and Reference Reagent Program), and the supernatant fluid was collected at a predetermined optimal time interval which showed the highest RT activity. The supernatant fluid was subjected to continuous-flow centrifugation at 35 //h in a Beckman CF-.^2 rotor. The pelleted virus suspension was layered over a 20/40"/p (w/v) discontinuous sucrose gradient and then centrifuged at 100 000 j? for 2 h in a Beckman SW27 rotor. The virus band was collected at the 20/40'!., sucrose interlace and then centrifuged for 1 h at 100000^ in a Beckman typc-35 rotor. The virus pellet was resuspended in Tris 10 mM. sodium chloride 150mMbulTer. pH 7-5.sothat 1 ml represented ihe yield from 1 / of the supernatant fluid ( x 1000). The virus particle count was determined to be I 33 x 10'" virus particles/ml. Tbe protein concentration was determined to be 0 87 mg;ml final concentration. The TCID5(, of this virus stock was determined by using the human CD4' H-9 cell line and was calculated to contain 10^ TClD^/mi of the virus stock. This value is lower than that obtained with other retroviruses and is reasoned to be most likely due to either the stripping of env proteins by the centrifugation procedures outlined above, or the use of the human H-9 cell line instead of non-human primate PBMC that were used to calculate the TClD^i. Two other lentiviruses were utilized. These included the HlV-l pool termed LAV,, which was grown in A3.0I cell line that was prepared by our laboratory by using a protocol similar to the protocol used in experiments with SIVsmm. The virus stock contained 2x 10^ TCIDw/nil. The olher Icntivirus used was HIV-2 rod subclone SR-3 [7] , which was prepared by our laboratory (with techniques similar to those used with the HIV-I) by using the SupTl cell line. This virus stock contained 1 x 10* TCIDWml.
Media
Media used throughout this study was RPMI 1640 supplemented wilh 100 U/ml of penicillin. 100/(g/ml streptomycin, 2 mM L-glutamine (all from Gmco, Grand Island. NY) and 10% heat-inactivated felal bovine serum (FBS; Hyclone Corp.. Logan. UT). Where indicated, these media were supplemented with 10 U/ml of rIL-2 (HolTman LaRoche. Nutley. NJ).
Isolation of lymphocytes ami CDS depletion
PBMC were isolated using a 60":. Percoll gradient as previously described [3] . They were washed twice in media, counted, and adjusted to a concentration of 2 x lO^ml. PHA-P (GtBCO) at a (inal concentration of 0 2% was added to cell eultures which were incubated at 37 C in a 7"^> CO; humidified atmosphere for 3 days. The cells were then washed twice, and aliquots ofthe cells were depleted of CDS ' T cells, using a biomagnctic separation system [8] . In brief. 10' lymphocytes were incubated with 100/il of Leu-2a (anti-CD8: Becton Dickinson. Mountain View, CA) on ice for 40 min. Excess antibody was removed by washing the cells in media. The media were then aspirated, and the cells were ne.xt incubated with 2 ml of goat anti-mouse immunoglobulinconjugated beads (Collaborative Research. Bedford, MA) for 40 min on ice. CD8+ cells were depleted by placing the lymphocytes in a magnetic field, CDS' cells were recovered from the beads by allowing them to incubate overnight at 37 C in a 7% COj humidified atmosphere.
FEcl cell line
The FEcl cells are an Epstein Barr virus (EBV)-transformed B cell line isolated from the PBMC of an SIV' sooty mangabey (FEc) as described elsewhere [8] , Briefly, PBMC from this monkey FEc were incubated overnight at 37 C in a 7"A< CO.--humidified incubator wilh supernatant fluid from the cullure of the B95 8 marmoset cell line (ATCC. Roekvillc. MD), The B95-8 eell line sheds the EBV in the supernatant fluid. Alter overnight incubation, the FEc cells were washed in medium and resuspended in Ihe same medium supplemented with 20"/. heatinactivated (56 C. 30 min) fetal caU scrum (FCS), The cells were cultured in 24-well tissue culture plates at 37 C in the 1% CO;-humidified incubator, and medium was replaced whenever required. By 6-8 weeks, transformed cells were readily apparent; these cells were expanded in 250-ml flasks and were carried as a cell line in the laboratory. The FEcl cell line consists of large EBV-transformed cells that are readily distinguishable from lymphocytes morphologically. For the first 10 tissue culture passages, these EBV-trans formed mangabey cells produced anti-SIV antibodies. However, antibody production by these cells has since ceased. The cells at about the twelfth passage were CD4 transfected with the gene that codes for the human CD4 molecule and with a neomycin resistance gene, using a Moloncyderived virus vector kindly provided by Dr R, Morgan (NH LBI. NIH). Selection for cells in whieh the CD4 gene was integrated was accomplished by growing the cells in the presence of 500 /ig, ml of neomycin. Expression of CD4 was confirmed by flow microfluoromctric (FMF) analysis, using fluorescein-conjugated MoAb Leu-3a, This cell line (which is oligodonal) has been stable for the last 2 years and has been shown consistently to express CD4,
N939 cell line
The N939 transformed cell line was derived from a rhesus macaque (named N939) by using herpes virus saimiri in a protocol essentially similar to the protocol used for preparing the EBV-transformed FEcl cell line as described above. The PBMC used were obtained from monkey N9.^9 before experimental inoeulation wilh lO"* TCIDMI of SIVsnim-9,
CDS .suppression of reverse transcriptase activity
The standard assay consisted of culturing PBMC from the monkey to be tested with 0-1 "A, PHA-P for 3 days in vitro at u concentration of 2 x 10" cells/ml. The PHA-P blasts were then layered over a Ficoll Hypaque gradient and centrifuged at 451) g, and the cells at the interface were collected. These cells were washed, and an aliquot was depleted of CD8+ cells as described above. Unfractionated PHA blasts were adjusted to 2 x 10" cells/ml, and the CD8-depleted PHA blasts were adjusted to contain approximately the same number of CD4' cells contained in the unfractionated PBMC. To each culture was added 20 fi\ of the X 1000 SIVsmm stock to yield about 2 x 10' TCI D^i per culture as an exogenous source of virus. The cultures were performed in media containing 10 U/ml of rIL-2 and were incubated at 37X in a 7% COj-humidifled atmosphere. Supernatant fluids from the cultures were collected every fourth day and assayed for reverse transcriptase (RT) activity, tnefl'orts to establish a standard assay, the CD4-expressing FEcl cell line was used as a constant target cell line. In this case. 5 x 10' ofthe FEcl cell line were cultured with SIVsmm alone (control) or cocultured with 1 X 10''day-3CD8* PHA blasts and the same dose of virus (2 X 10'TCIDw)in media containing 10 U/ml of rIL-2, In select experiments, instead of SIVsmm, an approximately similar dose of HIV-1 or HlV-2 (courtesy ofthe NIH. AIDS Research and Reference Reagent Program) was added to the cultures. Supernatant fluids from these cultures were collected and assayed for RT activity. In addition, some of the experiments used a dual-chamber culture assay [10] . in which FEcl cell line was cultured in the bottom chamber, and the autologous CDS • PHA blasts were placed in the top chamber in the same numbers as described above, and RT activity in the supernatant lluids was measured.
Transfection and CA T assay
The plasmids used were as follows: pU3RfII [11] ; plllextatlll 111 ]: NFkB mutant pU3Rni (Kb-) with a mutation at the NFkB binding sites [12] ; pCHlIO. an SV;-/i galactosidase reporter plasmid [13] . and a pSVrCAT plasmid. FEcl cells or the N939 cells (10') were washed twiee with PBS and resuspended in 1 ml of serum-free OPTI MEM (GIBCO), TO this suspension, plasmid .imountsof5/jg/10''cells (with the exception of plllextallll. for which only 2-5/ig/10''cells were used) and 25 ;ig of salmon sperm DNA (Sigma Chemical Co.. St Louis. MO) were added, Transfection was achieved by electroporation using a BioRad gene pulser apparatus, at 500 /(F. 400 il. and 450 V with the lime-constant automatically adjusted by the pulser for these settings. After transfection. the cells were washed and aliquoted at 2x10*' cells/well in a 24-weI! plate. To these plasmidtransfected FEcl or N939 ceil cultures varying numbers of effector cells at ratios of 1:1, 0 5:1 and 025:1 (eflector: target) were added. The cultures were incubated for 3 days. On day 3.60 ;(l of cell extract was prepared, and CAT activity was assayed as previously described [14] or by an ELISA for CAT (Boehringer Mannheim, Indianapolis. IN). It is important to note that comparisons of CAT activity were made among samples which were transfected at the same time, thus eliminating the possibility that the differences were due to transfection efficiency. The relative density measurements of the x-ray films which show C AT activity, as illustrated in the data shown in Figs 1, 2 and 3. were also quantified, and changes were calculated as a percentage of the values obtained with the ceil line that was cultured with media alone. In addition, phenotypic frequency and total number of viable cells in each culture were also determined,
Reproducibility of assay
Inhibition of CAT activity by CD8* T cells has been demonstrated consistently in our laboratory. All comparisons of CAT aetivity were made among samples that were transfected at the same time and then aliquoted. Thus, differences in CAT activity cannot be due to differences in transfection efficiency. Furthermore, for the experiment described in Fig. 3 , duplicate 5-/il aliquots from each culture extract were assayed for /J galactosidase activity to determine transfection efficiency as previously described [13] . Before the preparation of ceil extraets. cell counts were performed using trypan blue exclusion to ensure that ditTerenees in CAT activity were not secondary to cell death. 
RESULTS
Inhibition of viral replication by CDS' Tcells from naturally SIVinfected disease-resistant .sooty mangabeys
CDS * T cells from naturally infected seropositive sooty mangabeys and. for control purposes, CDS' T eells from (i) diseasesuseeptiblc rhesus macaques experimentally infected with 10"* TCIDsu of SIVsmm; (ii) uninfected rhesus macaques; and {iii) seronegative sooty mangabeys were assayed for their ability lo inhibit the replication of SIVsmm in equivalent numbers of autologoits CDS-depleted CD4'-enriched populations of mononuclear cells in vitro. CDS' T cells frotn the uninfected macaques did not detiionstrate measurable inhibitory activity. consistent with previously published data [5.6] . Of great importance was the observation that CDS * T cells frotn not only seropositive but also seronegative mangabeys mediated marked inhibition of SI V replication (Fig. 4) , The experiments have been repeated at least 10 times with different seropositive and seronegative mangabeys and experimentally infected and noninfcctcd rhesus macaques, and have given essentially similar results. These results were not secondary to differences in the total nutiiber of CD4' cells that remained in the cullure, since cultures of unfractionated and CD8-depleted PBMC from the same sample of blood, upon examination, contained a .similar number of total CD4' eeils as determined by FACS analysis. In addition, Ihe differences noted between tnaeaques and mangabeys were not secondary to any major difference (± 10%) in Ihe frequency or total number of CXiA'^ cells utilized, since the cultures were performed by using an essentially similar total tiumber orCD4* cells.
T cells from an SIV-infected sooty mangabey have the ability to inhibit HIV-1 and HIV-2
In an effort to examine the meehanisms contributing to the ability of CDS * Tcells to inhibit SIV replication. B cells from an SlV-infeeted seropositive sooty tnangabey (FEc) were transformed with EBV (see Materials and Methods) and transfected with a human CD4 gene. This eell line, termed FEcl, stably expresses CD4 as determined by FACS analysis and is replication-competent for SIV, As shown in Table 1 . autologous CDS ' T cells are able to inhibit SIV replication iti this cell line. Furthermore, this cell line is replicatioti-eompclcnt for HIV-1 and HlV-2. The data in Table I demonstrate the ability of CDS ' T cells from the mangabey FEc to inhibit the replication of these lentiviruses as well and suggest that the target of inhibition is most likely a common pathway used by this group of lentiviruses for viral replication. Other lentiviruses such as E!VA, visna.andCAEV. however, may use a different pathway. It is also not clear whether CDS' eells from an SIV-infected monkey ean inhibit the replication ofa non-ienti' retrovirus such as simian retrovirus D.
CDS* T cells can inhibit LTR-driven vital replication
Replieation of HIV-1 in infeeted lytnphoeytes is linked to lymphocyte aetivation [15] . Milogens. anti-CD.I. and anti-CD28-all of which mediate T eell aetivation-have also been shown to up-regulate virus replication in infeeted cells. There is a duplicate NFkB binding site in the LTR of HIV-1, and the binding of eeiluiar factors to these sites has been demonstrated [12, 16] . With this in mind, we sought to determine whether CDS' T cells could inhibit cellular activation of viral replication, FEel eells were transiently transfected with pU3RIII CAT plasmid. whieh contains the CAT gene driven by the HIV-1 LTR. These cells were cultured for 3 days in the presence or absence of autologous activated lymphoeytes. This experimental strategy was employed to determine if autologous lymphocytes had the functional capability to inhibit CAT activity,, providing a model that would permit us lo investigate the replication stage of lentivirus replication whieh was the target of inhibition mediated by the CDS' T eells. Figure I shows the data obtained from two separate experiments designed to address this issue. In experiment 1 (Fig. I) , comparison of the data obtained (lanes a and b) elearly demonstrates that the presence of autologous lymphoeytes inhibits the transactivation of the pU3Rni plasmid (>90% inhibition). Lanes c and d show data from cultures in which the FEcl cells were co-transfeeted with pU3RIll and plllextatlll, a plasmid which has the HIV-1 -LTR driving the tat gene and can efficiently produce tat in the absence of cellular binding factors. This plasmid not only transaetivates itself but will also transactivate pU3RIlI, Once again there is inhibition, although it is quantitatively less (<20%). suggesting that the trans tai is able to overcome some ofthe suppression. Since tat is produeed by a separate plasmid and stimulates the LTR independently of any cellularly derived factors, the data suggest that the suppressive effect is directed at cellular activation of viral replieation, Although it is elear that lane c may not be in the linear range of this assay, it is shown here only to demonstrate that the lat is able to transaetivatc and produce CAT activity.
In experiment 2 we sought to demonstrate further the ability of an enriched population of CDS' T cells (as opposed to unfractionated activated lymphocytes) to inhibit viral replication at the level of transcription. Lane e shows CAT aetivity derived from FEcl cells cultured alone. Lane f shows CAT aetivity derived from FEcl cells cultured with unfraetionated activated PBMC. while lane g shows CAT activity derived from FEcl eells cultured with CDS-depleted activated PBMC. Onee again, as was seen in experiment I, unfraetionated PBMC inhibited CAT activity (lane f, >9{)"A, inhibition). On the other hand, the FEel cell line co-cultured with CD8-depleted PBMC showed no significant inhibition (lane g. <\0"/,> inhibition). Addition ofthese highly enriehed populations of CDS"* T eells recovered from the depletion experiment \o the FEc cell line markedly inhibited CAT activity (lane i, >95"/<. inhibition) when compared with CAT activity in FEcl cells cultured as deseribed above (lane h). These data support the concept that CDS' T cells can inhibit viral replication at the level of LTRmediated viral activation. 
Inhibition of viral replication by a soluble faclor released by CDS' T cells
Experiments were designed to determine whether a soluble factor was responsible for the inhibition of viral replication. Two-chamber culture conditions were set up as previously described [10] . The data in Table 2 demonstrate that autologous lymphoeytes are able to inhibit viral replication in FEcl cells even when physically separated by a semipermeable membrane. However, the inhibition is not as potent as when a similar number of lymphocytes and FEel cells are co-cultured in the same chamber (43% versus 77%), In these experiments, viral replication was measured by assaying for RT activity. The total number of FEcl cells in each of these cultures at the end nf the incubation period was essentially similar. Thus, the inhibition was not secondary to differences in the growth ofthe FEcl cells in the various assay conditions. The protocol for the experiment shown in Fig. 2 was essentially similar to that described above, except that in the Fig, 2 protocol, viral replication was quantified by the measurement of CAT activity. As such, transwell cultures were set up with the transfected cells in the bottom well and with activated lymphocytes in the top. As seen in Fig. 2 , the presence ofthe aetivated lymphocytes separated by a semipermeable membrane (latiee, >95% inhibition) was just as potent as co-culture of unfractionated activated autologous lymphocytes (lane b. >90% inhibition) in inhibiting CAT activity when cotnpared with FEct cells cultured in media alone (lane a). Likewise, there is inhibition of CAT activity in the cells which were co-transfected with the pU3RllI and the plllextatlll. although once again the inhibition is less than that demonstrated in the cells transfected with pU3Rin alone (15-25%, lanes d-f). These data, taken together, suggest that CD8-mediated suppression occurs at the level of viral activation of replication, that a soluble factor is involved, and that sueh inhibition of virus replication may be mediated by a mechanism other than cytolytic destruction of virus-in fee ted target cells. The concept of a soluble factor involved in inhibition of virus replication is supported by similar data from other laboratories [10.17,181 . Furthermore, such findings suggest that this inhibition is non-MHC-restrieted and not due to conventional eytotoxic T cell function., and the data argue against the concept forwarded by Tsubota et al. [19] that phenotypically CDS' T cells, which require eell-cell contact and are MHC-restricted, are the .sole pathway involved in inhibition of virus replication.
CDS * T cells inhibit NFkB-mediated activation of viral replication
Several groups have demonstrated the ability of cellularly derived nuclear factors to bind to the NI'kB element of the LTR and activate virus replication [12, 15] . Thus, it was of interest to determine whether cellularly derived NFkB binding proteins were responsible for the activation ofthe pU3RIII in the FEcl ceils. In efforts to address this issue, a pU.'^RIll plasmid with a mutation in the NFkB binding motif (termed Kb ) was utilized. The FEcl cells were also transfected with an SV2 "cis'-activatcd /i galactosidase plasmid. This approach permitted the analysis of the efficiency of the transient transfection. which could be measured independently of CAT activity. Figure 3a . lane b. demonstrates the inhibition (>95'%.) of CAT activity derived from FEc I-transfected cells by co-culture with activated lymphocytes as compared with FEcl cellscultured with media alone (lane a). As seen in Fig. 3b . there is also some inhibition (10"^) of the SV; ji giilactosidasc activity by these lymphocytes; as the SV; promoter also contains an NFkB-like binding region, this slight inhibition may be caused by inhibition at this site. Lanes c and d show that there is virtually no CAT activity when the FEcl cells are transfected with the Kb CAT plasniid. On the other hand, these cells show substantial /i galactosidase activity, indicating that the iaek of CAT activity is not secondary to an unsuccessful transfection. Lanes e. f show once again that cells which arc cotransfected with pU3RITI and plllextatlll are less susceptible to CD8-mediatcd suppression (lane f showing 22"/.. inhibition when compared with lane e). That is, the tat provided in trans is able, to a certain degree, to mitigate this suppression. Finally, lanes g and h show CAT aetivity from eells which were cotransfected with the pU3RTll (Kb) and the plllextatlll. Each culture demonstrated substantial CAT activity, with about 10% lower CAT activity in lane h as eompared with lane g. These data suggest that in the absence of cellular NFkB binding factors, activation ofthe Kb plasmid can be driven in trans by tat. Since the Kb pU3RIII can be driven in the presenee of/(//, the 'lack' of activity demonstrated in lanes c and d is not due to a defective plasmid, but rather indicative of the fact that cellular activation ofthe LTR is dependent on the NFkB binding sites. Although the above data provide relative values for the degree of inhibition of CAT activity in the various experiments (numbers in parentheses in the text above are calculated from density analysis), the recent availability of an ELISA that measures CAT prompted us to repeat the above experiments to derive more precise data. Again, the FEc! cell line or a herpes transformed cell line from a rhesus macaque before experimental infection with SIVsmm-9 (termed N9S9) was each transiently transfected with pLJ3RI!I-LTR-CAT. the mutant pKb-LTR-CAT, the pU3RIII-LTR-CAT plus plllextatlll, and, for purposes of eonlrol. the plasmid SVrCAT. After transfection, 5 x 10* of each of these cells were eo-eultured in triplicate wells with autologous unfractionated or CDS-depleted PHA-activated PBMC for 3 days. In the case of N939, cultures consisted ofthe N939 herpes transformed cells, aliquots of which were transfected with each of the above plasmids and then co-cultured for 3 days with PHA-activated unfractionated or CD8-depleted PBMC from the same monkey (N939) before and after experimental infection with SIVsmm-9. As seen in Table 3 , ELISA results basically confirmed the results obtained using the TLC method for measuring CAT activity. It is important to note that the cells transfected with the pSV^-CAT plasmid did not appear to be influenced by unfractionated or CDS-depleted effector cells. However, FEel or the N939 cells that were transfeeted with pU3RIIl showed marked inhibition of CAT activity (/'<0001) when eo-culturcd with unfractionated FEc PBMC or N939 PBMC after SIV infection but not before SIV infeetion, respectively. The inhibition appeared to be related to the dose of unfractionated PBMC. Furthermore, no CAT was tneasurable in the cells transfected with pKb" piasmid. and the inhibition that was mediated by CD8+ eells in cells that were transfected with pU3RIII alone was overcome, to a large extent, by eo-transfection with plllextatlll. Tolal cell counts and viability eeli counts were performed in each of the eelt cultures. These data showed that all cultures were >95% viable, with the same total number of cells (range 5 75 x 10^ to 6x 10^) at the end of the culture period, suggesting that the degree of inhibition of CAT activity could not be secondary to eytotoxic mechanisms. Studies performed by using ^'Cr-lahclled FEcl target cells that were transfected with each of the above plastnids and co-ineubated with unfractionated or CD8-enriched FEcl cells failed to demonstrate significant cytolytic activity (<5% net cytoioxicity, data not shown). Appropriate negative and positive controls were included in each experiment. One should also note that the experiment as shown in Table 3 has been repeated three times, with each experiment yielding basically identical data. Taken together, we believe these data demonstrate that (i) most viral activation in this model is mediated by NKkB binding proteins; (ii) the ability of CD8' T cells to inhibit viral replication in this model is directed at these cellularly derived factors.
DISCUSSION
Using the mangabey model of SIV infection, we have sought to examine the mechanism(s) behind CD8-mediated suppression of viral replication, Mangabeys are naturally infected with SIV yet display none of the clinical sequelae of such infection, therefore providing a unique model to study potential protective immune effector mechanisms to retroviral infection in the absence of concomitant opportunistic infection. It is intriguing that not only do sooly mangabeys possess CD8* T cells which inhibit retroviral replication,, but seronegative sooty mangabeys also possess such elTector cells, in some cases many years before they seroconvert. Such findings raise the possibility that perhaps the early devclopmeni of this lineage of CDS* T cells in mangabeys before frank seroconversion may contribute in some v^ay to their relative resistance to SIV infection. In fact, our laboratory has preliminary data (unpublished) that seronegative infant mangabeys ( < 2 years old) possess such CD8 " Tcells.
The ability of CDS' T cells from an SIV-infected sooty mangabey to inhibit HIV-1 and HIV-2 infection was addressed using a CD4" EBV-transformed mangabey B cell line. It was found that the CD8' T cells from the SIV-infected mangnbey could, in fact, inhibit HIV-1 and HlV-2 replication in vitro. Since all three ofthese viruses arc lentiviruses, it suggests that the pathway of inhibition by CD8^ T cells is common to lentiviruses and not strictly antigen-specific. However, it is important to realize that since we are using PHA-activated CD8' T cells, we are examining the etTector step of this inhibition and not the antigen recognition step. Presumably. CD8' T cells recognize SIV in vivo in an antigen-specific fashion which leads to the expansion of these cells. The expansion of such eells may indeed be SI V-spccific. although the effect of such eells is not SIV-specific. The antigen responsible for Lhis expansion has yet to be elucidated. However, the data in Fig. 3 show only minimal inhibition of fi galactosidase driven by the simian virus 40 promoter, suggesting that this mechanism has some degree of specificity. This specificity is further exemplified by the lack of inhibition of CAT by CD8' cells in cultures transfeeted with the pSV^ plasmid (see Table 3 ), in this regard, it would be interesting to determine if CD8* T eells from an SIVinfected mungabey have the ability to inhibit non-lentivirus retroviruses such as the simian retrovirus D.
LIsing dual-chamber culture conditions, we demonstrated that CD8-mediated suppression of both SIV replication and LTR-driven CAT activity ean be mediated by a soluble factor. Such data arc in agreement with the findings ol'Walker & Levy [10] and Brinchmann et al. [18) . both of whom were measuring suppression of HI V-1 replication by human CD8'^ Tcells. These transwell experiments suggest that CD8-mediated inhibition is not simply CTL activity against virally infected cells. Such data, however, conflict with the views of Tsubota et al. [19] . who provide phenotypic evidenee that CD8 suppression of viral replication is mediated by eytotoxic T cells by virtue of the cell surface markers expressed by sueh cells. Our laboralory has been unable to correlate CD8-mediated suppression with cytolysis of infected cells (unpublished). In this regard, it is important to note that Walker et al. [17] and Wiviott et al. [20] have reported the isolation of CD8* T eell clones which inhibit viral replication yet lack CTL activity.
It is now apparent that the interaction of HI V-1 with Tcells and monocytes exceeds the mere tropism of the virus for these cell types. Antigen, anti-CD3, mitogens. and various cytokines^-all ofwhich are able to stimulate T cell activation-also activate virus in latently infected cells [21] . At the molecular level, several groups have demonstrated tlic ability of NFkB binding proteins to enhance viral replication in both T cell and monocyte cell lines [12.22] . Using an NFkB mutant pU3RIII reporter gene, we have demonstrated that most viral transcription, as reflected by CAT activity in the FEcl cells, is positively influenced by NFkB binding proteins, and this activity can be markedly inhibited by CDS' T cells, CelLs which were cotransfected with the pU3RIil and plllextatlll plasmids generated higher CAT activity, as expected. The co-transfected cells were inhibited by CDS ' cells to a much lesser extent than when tar was absent. In civo. CD8-mediated suppression may therefore be overcome if there is an abundance of fat within an infected cell. Reports concerning the ability of cis-acting viral factors to induce replication in NFkB viral mutants have recently been presented [23] .
Since viral replication is so intimately linked to factors responsible for T cell activation,, it is unclear whether CD8' T cell-mediated inhibition is primarily an antiviral response or an immunosuppressive response. There is a definite down-regulation of T-hclper cell function in HIV-1 infection [24] , Shearer et at. [25] have shown that asymptomatic HIV-1-infected individuals have suppressed T helper cell function to certain nominal antigens. Via *•/ ai. [26] have proposed thai this represents active immunosuppression and may be protective by preventing the activation and subsequent infection ofthese cells. We hypothesize, therefore, that the observed suppression may be due to the ability of CD8+ Tcells to down-regulate NFkBmediated aetivation of infected cells. In the future we hope to use this model to characterize further the role ofthe NFkB protein family on cellular activation and the potential role of CD8' cells in regulating this axis.
